505(b)2 and Drug Approval Pathways

Join us for another episode of the Ambulatory Care Academy Podcast where we have an insightful discussion with Darell Connor, AmCA student representative, Doctor of Pharmacy Candidate 2025 from Creighton University and Pharmacy Corporate Project Manager with the American Oncology Network. In this AmCA Podcast, Darell discusses the 505(b)2 drug approval pathways and its impacts. Drug approval has evolved, and how patients may eventually get medications has expanded beyond "FDA drug approval". Listen in as we converse with Darell and learn how the 505(b)2 pathway will impact ambulatory care pharmacy.